A Study of COVID 19 Convalescent Plasma in High Risk Patients With COVID 19 Infection
Completed · Phase 2
Conditions studied: Coronavirus, COVID-19, Convalescent Plasma
In brief
Purpose of Study • The purpose of this study to evaluate, the effectiveness of convalescent plasma in combatting the symptoms and effects of the coronavirus disease, COVID-19. Beyond supportive care, there are no proven treatment options for COVID-19.
Key facts
- Study ID
- NCT04392232
- Run by
- TriHealth Inc.
- People needed
- 159
- Starts
- 2020-05-05
- Expected to finish
- 2021-09-21
- Last updated by the study team
- 2021-12-07
Who can join
Age: 16 and older. Sex: any. Healthy volunteers: accepted.
Where it is running
- Good Samaritan Hospital — Cincinnati, Ohio, United States
- Bethesda North Hospital — Cincinnati, Ohio, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.